Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome

International Clinical Psychopharmacology

Volumn 25, Issue 4, 2010, Pages 214-217

  Farabaugh, Amy H ^a   Bitran, Stella ^a   Witte, Janet ^a   Alpert, Jonathan ^a   Chuzi, Sarah ^a   Clain, Alisabet J ^a   Baer, Lee ^a   Fava, Maurizio ^a   McGrath, Patrick J ^b   Dording, Christina ^a   Mischoulon, David ^a   Papakostas, George I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Antidepressants; Anxiety; Anxious depression; Depression; Predictors; Remission

Indexed keywords

FLUOXETINE;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; RELAPSE; REMISSION; SOMATIZATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLUOXETINE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 77953723909     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/YIC.0b013e328339fbbd     Document Type: Article

References (16)

1. Bech P, Wilson P, Wessel T, Lunde M, Fava M (2009). A validation analysis of two self-reported HAM-D6 versions. Acta Psychiatr Scand 119:298-303.
2. Chen C, Ridler K, Suckling J, Williams S, Fu C, Merlo-Pich E, Bullmore E (2007) Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry 62:407-414.
3. Cusin C, Fava M, Amsterdam JD, Quitkin FM, Reimherr FW, Beasley CM Jr, et al. (2007). Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications. J Clin Psychiatry 68:52-57.
4. Erdfelder E, Faul F, Buchner A (1996). GPOWER: a general power analysis program. Behav Res Methods Instrum Comput 28:1-11.
5. Farabaugh A, Mischoulon D, Fava M, Wu SL, Mascarini A, Tossani E, et al. (2005). The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients. Int Clin Psychopharmacol 20:87-91.
6. Fava M, Uebelacker LA, Alpert JE, Nierenberg AA, Pava JA, Rosenbaum JF (1997). Major depressive subtypes and treatment response. Biol Psychiatry 42:568-576.
7. Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, et al. (2008). Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry 165: 342-351.
8. First MB, Spitzer RL, Gibbon M, Williams JBW (1996). Structured clinical interview for the DSM-IV Axis I disorders-patient edition. New York: Biometrics Research Department, New York State Psychiatric Institute.
9. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
10. Henriques SG, Fráguas R, Iosifescu DV, Menezes PR, de Lucia MC, Gattaz WF, et al. (2009). Recognition of depressive symptoms by physicians. Clinics (Sao Paulo) 64:629-635.
11. Kanai T, Takeuchi H, Furukawa TA, Yoshimura R, Imaizumi T, Kitamura T, et al. (2003). Time to recurrence after recovery from major depressive episodes and its predictors. Psychol Med 33:839-845.
12. McGrath PJ, Stewart JW, Quitkin FM, Chen Y, Alpert JE, Nierenberg AA, et al. (2006). Predictors of relapse in a prospective study of fluoxetine treatment of major depression. Am J Psychiatry 163:1542-1548.
13. Mussell M, Kroenke K, Spitzer RL, Williams JBW, Herzog W, Lowe B (2008). Gastrointestinal symptoms in primary care: prevalence and association with depression and anxiety. J Psychosom Res 64:605-612.
14. Trivedi MH (2004). The link between depression and physical symptoms. Prim Care Companion J Clin Psychiatry 6 (Suppl 11):12-16.
15. Trivedi MH, Morris DW, Grannemann BD, Mahadi S (2005). Symptom clusters as predictors of late response to antidepressant treatment. J Clin Psychiatry 66:1064-1070.
16. Wernicke JF, Dunlop SR, Dornseif BE, Bosomworth JC, Humbert M (1988). Low-dose fluoxetine therapy for depression. Psychopharmacol Bull 24:183-188.